Human IgA, IgG and IgM AssayLite Multiplex Fluorescent Immunoassay Kit |
|||
FI700161M3 | AssayPro | 96 Well Plate | EUR 1472.4 |
Human IgG antibody Laboratories manufactures the igg and igm spike on spep reagents distributed by Genprice. The Igg And Igm Spike On Spep reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike IgM. Other Igg products are available in stock. Specificity: Igg Category: And Group: Igm Spike
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
||
ChemNorm | 48T | EUR 398.4 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
||
GenAsia Biotech | 48T | EUR 346.8 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
||
GenAsia Biotech | 96T | EUR 559.2 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
||
Qayee Biotechnology | 96T | EUR 433.2 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
||
Shanghai YL Biotech | 48T | EUR 435 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
||
Shanghai YL Biotech | 96T | EUR 562.5 |
SeraMir Control spike-in Small RNA and qPCR assay |
||
SBI | 100 assays | EUR 181 |
Rabbit monoclonal Anti-MERS Spike protein (S1/RBD/MERS-RBD) IgG (Neutralizing) |
|||
MERS122-M | Alpha Diagnostics | 100 ul | EUR 781.2 |
91 SOW Matrix Spike |
|||
CLPP-MS91 | Scientific Laboratory Supplies | 1ML | EUR 198 |
91-SOW Surr Spike |
|||
CLPP-S91H | Scientific Laboratory Supplies | 1ML | EUR 84 |
Spike Glycoprotein Antibody |
|||
20-abx300551 | Abbexa |
|
|
90-SOW MATRIX SPIKE |
|||
CLPP-MS90H | Scientific Laboratory Supplies | 1ML | EUR 258 |
91-SOW Matrix Spike |
|||
CLPP-MS91H | Scientific Laboratory Supplies | 1ML | EUR 103.2 |
Mouse Monoclonal Anti-Porcine epidemic diarrhea virus Spike protein S1 (PEDV-S1) IgM, unlabeled |
|||
PEDV13-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
SARS (IN3) Spike Peptide |
|||
3225P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN3) Spike peptide |
SARS (IN1) Spike Peptide |
|||
3221P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN1) Spike peptide |
SARS (IN2) Spike Peptide |
|||
3223P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) SARS (IN2) Spike peptide |
91 SOW Surrogate Spike |
|||
CLPP-S91 | Scientific Laboratory Supplies | 2ML | EUR 247.2 |
EPH Surrogate Spike Mix |
|||
NJDEP-EPH-SS | Scientific Laboratory Supplies | 1ML | EUR 242.4 |
SARS-CoV Spike Protein |
|||
abx060655-1mg | Abbexa | 1 mg | EUR 2030.4 |
SARS-CoV Spike Antibody |
|||
3225-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3225-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |